TP53 mutations as predictor of response and longer survival under immune checkpoint inhibitors in advanced non-small cell lung cancer

Authors :: Valérie Gounant
Baptiste Abbar
J. Pluvy
S. Brosseau
Céline Namour
Marina Nguenang
Claire Danel
Aurélie Cazes
Gérard Zalcman
Antoine Khalil
Nathalie Théou-Anton
Sandra Assoun
Source :: Annals of Oncology. 29:vi19
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
business.industry
Immune checkpoint inhibitors
Cancer research
Medicine
Hematology
Non small cell
business
Lung cancer
medicine.disease
Tp53 mutation

Full Text Access

Tools